Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
about
Asap: a framework for over-representation statistics for transcription factor binding sitesAberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancerThe histone demethylase Jhdm1a regulates hepatic gluconeogenesisEpigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaDown-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1Enriched transcription factor binding sites in hypermethylated gene promoters in drug resistant cancer cellsVILIP-1 downregulation in non-small cell lung carcinomas: mechanisms and prediction of survival.AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinomaIdentification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression.C/EBPδ gene targets in human keratinocytes.HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes.CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cellsGenome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features.Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 casesCCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.The CEBPA gene is down-regulated in acute promyelocytic leukemia and its upstream promoter, but not the core promoter, is highly methylatedGermline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.Expression of the mismatch repair gene hMLH1 is enhanced in non-small cell lung cancer with EGFR mutationsCCAAT/enhancer binding protein β is dispensable for development of lung adenocarcinoma.Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterationsOxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing.Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590.Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significanceThe significance of epigenetic alterations in lung carcinogenesis.Deficiency of CCAAT/enhancer binding protein family DNA binding prevents malignant conversion of adenoma to carcinoma in NNK-induced lung carcinogenesis in the mouseGermline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.Dysregulation of the C/EBPalpha differentiation pathway in human cancer.Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex.Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma.C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpointDNMT1-interacting RNAs block gene-specific DNA methylation.MicroRNA dysregulation in gastric cancer: a new player enters the game.15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.The role of CCAAT/enhancer binding protein (C/EBP)-alpha in osteogenesis of C3H10T1/2 cells induced by BMP-2.Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells.
P2860
Q21092224-FC4F8A7A-E6EF-4100-8228-76C8BB745985Q21092374-712A64D3-83FC-4CDD-B049-AD3F32B5E1A6Q21144913-CF5D89EF-A9E2-4C35-A133-7C085AD9B911Q24652017-F80100D4-AE50-4C82-8EE1-23AF8AD9FB8AQ24655144-5FDA7546-F85F-47D2-8D67-C3058B42729CQ28390582-BC25045F-D321-49E2-9F56-8C9EB0957261Q33321264-AF24DC37-BFD7-486B-93ED-BC2EDB2BBE94Q33501737-7FB10A54-6C7C-4B2E-AA36-7155CB775802Q33560404-3150FC46-DAE9-435C-B5F1-F84736478668Q33726245-BFB1EA23-4E31-4ADC-A110-97E3F88FDF38Q33745060-D42FC4DE-32E6-4362-828B-EA8AB67A5C88Q33818402-EE06BF9C-FE46-4C81-827C-47A5E854705EQ33825575-C4B6BD75-F722-47C2-A2F5-F03E66FF3EC3Q33899490-CA013EE4-65DF-4589-9939-3F290680CE5EQ34156717-D2001F78-C424-43DF-B53D-D182501A5588Q34577037-D232FE51-F216-4464-971B-36FE72C9C193Q34599904-5FD91049-B144-41D5-A445-FD1028CDBF7FQ34750625-37E88BD8-78EB-426B-A3F4-D9DC86D8A22CQ35032574-4E064BB0-5DF9-41D9-8210-924D540CD411Q35036471-96599293-56AC-4C1B-A94B-6E44855950ECQ35175264-8B94B042-2F40-4305-A449-59699F875DCCQ35597950-102B7627-8B72-4A5E-8D1E-6E682FB84251Q35841917-A307FF3F-237D-4DBA-8DAD-2096D2FAC011Q36010758-8411F997-2613-4757-89F0-8F6B3EAD63DDQ36049618-D6D8D202-0B77-4012-9DFE-736C28851CF8Q36141686-0D3BBAA4-5DEB-4FB7-8D69-52F0B29B07BEQ36449835-46EA1DA7-0401-436F-9382-A005129B6BD3Q36457427-FE81C654-63C7-4AAC-9447-3861954C5AA1Q36544436-12A7CCEA-5FEF-4BB7-B646-184E90A06503Q36847856-787886DD-5E37-4261-A022-3C0202DE1D25Q37104787-1980B6CA-1AF2-4C35-BAB8-2E8F685B1D20Q37142723-309F8A8A-16DD-44EB-8511-F821E5C6551AQ37170593-706447F9-EE1D-41ED-A19B-13A8257A547BQ37177505-CF577371-DFC3-4822-8C9E-17BCC4B276D2Q37341405-984ADF29-709D-435C-9393-357E2037DBC8Q37408576-BFBF73A3-D540-46F4-A502-6F7A007F2AE3Q37783909-8566F8F7-719F-45A5-A8D2-A209053FF6DCQ38289660-3975D592-8F99-439A-91E2-DECF12FBE041Q38357733-3C542D96-6C98-43B8-8244-9604341F812DQ38358635-66DAAF16-4A98-484D-9382-305E97B587BD
P2860
Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Epigenetic modulation of tumor ...... alpha activity in lung cancer.
@ast
Epigenetic modulation of tumor ...... alpha activity in lung cancer.
@en
Epigenetic modulation of tumor ...... alpha activity in lung cancer.
@nl
type
label
Epigenetic modulation of tumor ...... alpha activity in lung cancer.
@ast
Epigenetic modulation of tumor ...... alpha activity in lung cancer.
@en
Epigenetic modulation of tumor ...... alpha activity in lung cancer.
@nl
prefLabel
Epigenetic modulation of tumor ...... alpha activity in lung cancer.
@ast
Epigenetic modulation of tumor ...... alpha activity in lung cancer.
@en
Epigenetic modulation of tumor ...... alpha activity in lung cancer.
@nl
P2093
P2860
P356
P1476
Epigenetic modulation of tumor ...... alpha activity in lung cancer.
@en
P2093
Björn Hackanson
Carl Morrison
Christoph Plass
Gregory A Otterson
Romulo Martin Brena
Yasuhiro Tada
P2860
P304
P356
10.1093/JNCI/DJJ093
P407
P577
2006-03-01T00:00:00Z